Kannaway Parent Medical Marijuana Generates $12.2M, PrestoDoctor Boosts Cannabis Sativa

Medical Marijuana Touts Positive Adjusted EBITDA In Q3, Net Revenue Of $12.2 Million

Medical Marijuana Inc. MJNA has generated $12.2 million in net revenue over the third quarter. That's a sequential increase of 11.25%.

The earnings report came on the heels of entering the CBN market through its subsidiary Kannaway.

The San Diego cannabis company also reported a positive adjusted EBITDA of $175,755.

Gross profit for the quarter amounted to $9.1 million, as GAAP Sales and Marketing expenses dropped as a percentage of sales from 51.9% to 49.3%, on a sequential basis.

Kannaway's Japanese division saw its best revenue month ever in August.

In July, HempMeds — also a Medical Marijuana subsidiary — partnered with Gelson's Market to supply Southern California's customers with its CBD topical and beauty products.

In addition, HempMeds named Vince DiMella U.S. director of sales and marketing, while former HempMeds president Todd Morrow was promoted to CFO and CIO in September, alongside the company's co-founder Michelle Sides who now serves as CLO. The company also hired Robert Wells as Vice President of Finance.

"We feel very optimistic about finishing out the year strong, with consumers interested in wellness at an all-time high headed into the holidays," CEO Dr. Stuart Titus stated Tuesday.

Cannabis Sativa's PrestoDoctor Generates Over $1.6M In Revenue In Nine Months

Cannabis Sativa, Inc. CBDS disclosed its revenue for the third quarter amounted to $459,786 and roughly $1.7 million for the nine months ended September 30. That's a year-over-year increase of 137%.

PrestoDoctor, the Company's telemedicine platform, attributed with $1,602,599 in revenue for the nine months, as its GK Manufacturing and Packaging subsidiary remained in the start-up phase during the period.

The telemedicine portal serves patients across seven states, including California, Nevada, New York, Oklahoma, Missouri, Pennsylvania, and Illinois.

"We are pleased to report strong numbers during this pandemic," President David Tobias said, adding that “there has been a broadened acceptance of telehealth due to the Coronavirus."

The company also noted its identifying opportunities to expand to Ohio, Virginia, and Massachusetts.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsMarketsPress Releasescannabis industryCannabis SativaCBDcbnEBITDAfinancialsHempMedsInc.Kannaway appointmentsmarijuana stocksmedical marijuanaPrestoDoctorreportrevenuestelemedicine platformthird quarter earnings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...